Outside Section 134
Data Current as of: 8/19/2015
Section 40 of chapter 258 of the acts of 2014 is hereby amended by adding the following words:- ; provided, however, that until the first draft is issued, any drug product approved by the federal Food and Drug Administration for abuse deterrent labeling shall be considered an interchangeable abuse deterrent drug product for the purposes of this act. When issued, the first draft shall also include guidelines to implement the transition to the formulary of abuse deterrent drugs with the least interruption to patient care.
I am vetoing this section because the United States Food and Drug Administration's approval of abuse deterrent labeling for a drug product does not resolve the issue of drug interchangeability. These designations should therefore await the drug formulary commission's review and determination, which will commence in August of 2015.